This will be filed to report incomplete coaptation, recurrent mitral regurgitation, and tissue damage.It was reported that on (b)(6) 2023 a mitraclip procedure was performed to treat mixed mitral regurgitation (mr) grade 4+ with a restricted posterior leaflet and dilated left atrium.Two clips were successfully implanted, and the procedure was concluded with a resulting mr of grade 1+.On (b)(6) 2023 the patient was referred to the hospital for swelling.A transthoracic echocardiogram was performed and it was observed both implanted clips detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachment/slda) and chordal rupture occurred.This caused mr to increase to a grade of 4+.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history did not indicate a lot-specific product issue.All available information was investigated, and the reported slda appears to be related to patient conditions (tethered posterior leaflet).Unspecified tissue injury, mitral valve insufficiency/ regurgitation (recurrent mr) and swelling/edema appear to be due to the slda.Mitral regurgitation, swelling/edema and tissue injury/damage are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Hospitalization was a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.The additional mitraclip device referenced in b5 is being filed under a separate medwatch report number.
|